title: The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
abstract: The ability of Epstein-Barr virus (EBV) to spread and persist in human populations relies on a balance between host immune responses and EBV immune evasion. CD8(+) cells specific for EBV late lytic cycle antigens show poor recognition of target cells compared to immediate early and early antigen-specific CD8(+) cells. This phenomenon is due in part to the early EBV protein BILF1, whose immunosuppressive activity increases with lytic cycle progression. However, published data suggest the existence of a hitherto unidentified immune evasion protein further enhancing protection against late EBV antigen-specific CD8(+) cells. We have now identified the late lytic BDLF3 gene as the missing link accounting for efficient evasion during the late lytic cycle. Interestingly, BDLF3 also contributes to evasion of CD4(+) cell responses to EBV. We report that BDLF3 downregulates expression of surface major histocompatibility complex (MHC) class I and class II molecules in the absence of any effect upon other surface molecules screened, including CD54 (ICAM-1) and CD71 (transferrin receptor). BDLF3 both enhanced internalization of surface MHC molecules and reduced the rate of their appearance at the cell surface. The reduced expression of surface MHC molecules correlated with functional protection against CD8(+) and CD4(+) T cell recognition. The molecular mechanism was identified as BDLF3-induced ubiquitination of MHC molecules and their subsequent downregulation in a proteasome-dependent manner.
  
  
  OBJECTIVE
  Immune evasion is a necessary feature of viruses that establish lifelong persistent infections in the face of strong immune responses. EBV is an important human pathogen whose immune evasion mechanisms are only partly understood. Of the EBV immune evasion mechanisms identified to date, none could explain why CD8(+) T cell responses to late lytic cycle genes are so infrequent and, when present, recognize lytically infected target cells so poorly relative to CD8(+) T cells specific for early lytic cycle antigens. The present work identifies an additional immune evasion protein, BDLF3, that is expressed late in the lytic cycle and impairs CD8(+) T cell recognition by targeting cell surface MHC class I molecules for ubiquitination and proteasome-dependent downregulation. Interestingly, BDLF3 also targets MHC class II molecules to impair CD4(+) T cell recognition. BDLF3 is therefore a rare example of a viral protein that impairs both the MHC class I and class II antigen-presenting pathways.
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Laura L
authors.initials: LL
authors.lastname: Quinn
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Luke R
authors.initials: LR
authors.lastname: Williams
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Claire
authors.initials: C
authors.lastname: White
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Calum
authors.initials: C
authors.lastname: Forrest
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom J.Zuo@bham.ac.uk.
authors.forename: Jianmin
authors.initials: J
authors.lastname: Zuo
authors.affiliation: Institute of Immunology & Immunotherapy (III), College of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
authors.forename: Martin
authors.initials: M
authors.lastname: Rowe
mesh_terms: D002460:Cell Line; D015536:Down-Regulation; D004854:Herpesvirus 4, Human / Q000276:immunology* / Q000502:physiology*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D000949:Histocompatibility Antigens Class II / Q000378:metabolism*; D006801:Humans; D057131:Immune Evasion; D008285:Major Histocompatibility Complex; D008562:Membrane Glycoproteins / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D054875:Ubiquitination; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: C109483:BDLF-3 protein, Human herpesvirus 4; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D014764:Viral Proteins